FRAMSTAELLNING AV SAOSOM 5ALFA-REDUKTAS-INHIBITORER ANVAENDBARA 4-AZA-17-SUBSTITUERAD-5ALFA-ANDROSTAN-3-ONER

A process for preparing 17 beta -carboxy-4-androsten-3-ones comprising the steps of (1) reacting a 17 beta -(1-ketoethyl)-5-androsten-3-ol, for example, pregnenolene, with pyridine and iodine to form a pyridinium iodide compound; (2) reacting the pyridinium iodide compound with alkali metal methoxid...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: RASMUSSON GARY HENRY, UTNE TORLEIF, JOHNSTON DAVID BRUCE RANDOLPH, REINHOLD DONALD FLOYD, JOBSON RONALD BRADFORD
Format: Patent
Sprache:fin
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator RASMUSSON GARY HENRY
UTNE TORLEIF
JOHNSTON DAVID BRUCE RANDOLPH
REINHOLD DONALD FLOYD
JOBSON RONALD BRADFORD
description A process for preparing 17 beta -carboxy-4-androsten-3-ones comprising the steps of (1) reacting a 17 beta -(1-ketoethyl)-5-androsten-3-ol, for example, pregnenolene, with pyridine and iodine to form a pyridinium iodide compound; (2) reacting the pyridinium iodide compound with alkali metal methoxide in methanol to form a methyl-5-androsten-3-ol-17 beta carboxylate; (3) oxidizing the product of Step (2) preferably with aluminum isopropoxide to form methyl-4-androsten-3-one-17 beta -carboxylate; and (4) hydrolyzing the product of Step (3) to the corresponding 17 beta -carboxylic acid, salt, or ester. The 17 beta -carboxy-4-androsten-3-ones are useful as intermediates for preparation of N-substituted-17 beta -carbamoylandrost-4-en-3-one and 4-aza-17 beta -substituted-5 alpha -androstan-3-one 5 alpha reductase inhibitors.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_FI67389BB</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>FI67389BB</sourcerecordid><originalsourceid>FETCH-epo_espacenet_FI67389BB3</originalsourceid><addsrcrecordid>eNqFjLEKwjAQQLs4iPoLkh-4QapWx4u52GB7gUvawaUUiVPRQv1_FHR3est7b54NVrAOEamq2PFZYasC-uBrtcPKIgiZ5hIxgOPSaRe9kCjkFomNRkG1BbwibAoIjQ7RxYYEDXxjZCP-M2fIwTPJMpvd-2FKqx8X2dpSPJWQxmeXprG_pUd6ddbti_xw1Dr_K7wBrHk1dQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>FRAMSTAELLNING AV SAOSOM 5ALFA-REDUKTAS-INHIBITORER ANVAENDBARA 4-AZA-17-SUBSTITUERAD-5ALFA-ANDROSTAN-3-ONER</title><source>esp@cenet</source><creator>RASMUSSON GARY HENRY ; UTNE TORLEIF ; JOHNSTON DAVID BRUCE RANDOLPH ; REINHOLD DONALD FLOYD ; JOBSON RONALD BRADFORD</creator><creatorcontrib>RASMUSSON GARY HENRY ; UTNE TORLEIF ; JOHNSTON DAVID BRUCE RANDOLPH ; REINHOLD DONALD FLOYD ; JOBSON RONALD BRADFORD</creatorcontrib><description>A process for preparing 17 beta -carboxy-4-androsten-3-ones comprising the steps of (1) reacting a 17 beta -(1-ketoethyl)-5-androsten-3-ol, for example, pregnenolene, with pyridine and iodine to form a pyridinium iodide compound; (2) reacting the pyridinium iodide compound with alkali metal methoxide in methanol to form a methyl-5-androsten-3-ol-17 beta carboxylate; (3) oxidizing the product of Step (2) preferably with aluminum isopropoxide to form methyl-4-androsten-3-one-17 beta -carboxylate; and (4) hydrolyzing the product of Step (3) to the corresponding 17 beta -carboxylic acid, salt, or ester. The 17 beta -carboxy-4-androsten-3-ones are useful as intermediates for preparation of N-substituted-17 beta -carbamoylandrost-4-en-3-one and 4-aza-17 beta -substituted-5 alpha -androstan-3-one 5 alpha reductase inhibitors.</description><edition>3</edition><language>fin</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; STEROIDS</subject><creationdate>1984</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19841130&amp;DB=EPODOC&amp;CC=FI&amp;NR=67389B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19841130&amp;DB=EPODOC&amp;CC=FI&amp;NR=67389B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>RASMUSSON GARY HENRY</creatorcontrib><creatorcontrib>UTNE TORLEIF</creatorcontrib><creatorcontrib>JOHNSTON DAVID BRUCE RANDOLPH</creatorcontrib><creatorcontrib>REINHOLD DONALD FLOYD</creatorcontrib><creatorcontrib>JOBSON RONALD BRADFORD</creatorcontrib><title>FRAMSTAELLNING AV SAOSOM 5ALFA-REDUKTAS-INHIBITORER ANVAENDBARA 4-AZA-17-SUBSTITUERAD-5ALFA-ANDROSTAN-3-ONER</title><description>A process for preparing 17 beta -carboxy-4-androsten-3-ones comprising the steps of (1) reacting a 17 beta -(1-ketoethyl)-5-androsten-3-ol, for example, pregnenolene, with pyridine and iodine to form a pyridinium iodide compound; (2) reacting the pyridinium iodide compound with alkali metal methoxide in methanol to form a methyl-5-androsten-3-ol-17 beta carboxylate; (3) oxidizing the product of Step (2) preferably with aluminum isopropoxide to form methyl-4-androsten-3-one-17 beta -carboxylate; and (4) hydrolyzing the product of Step (3) to the corresponding 17 beta -carboxylic acid, salt, or ester. The 17 beta -carboxy-4-androsten-3-ones are useful as intermediates for preparation of N-substituted-17 beta -carbamoylandrost-4-en-3-one and 4-aza-17 beta -substituted-5 alpha -androstan-3-one 5 alpha reductase inhibitors.</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>STEROIDS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1984</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFjLEKwjAQQLs4iPoLkh-4QapWx4u52GB7gUvawaUUiVPRQv1_FHR3est7b54NVrAOEamq2PFZYasC-uBrtcPKIgiZ5hIxgOPSaRe9kCjkFomNRkG1BbwibAoIjQ7RxYYEDXxjZCP-M2fIwTPJMpvd-2FKqx8X2dpSPJWQxmeXprG_pUd6ddbti_xw1Dr_K7wBrHk1dQ</recordid><startdate>19841130</startdate><enddate>19841130</enddate><creator>RASMUSSON GARY HENRY</creator><creator>UTNE TORLEIF</creator><creator>JOHNSTON DAVID BRUCE RANDOLPH</creator><creator>REINHOLD DONALD FLOYD</creator><creator>JOBSON RONALD BRADFORD</creator><scope>EVB</scope></search><sort><creationdate>19841130</creationdate><title>FRAMSTAELLNING AV SAOSOM 5ALFA-REDUKTAS-INHIBITORER ANVAENDBARA 4-AZA-17-SUBSTITUERAD-5ALFA-ANDROSTAN-3-ONER</title><author>RASMUSSON GARY HENRY ; UTNE TORLEIF ; JOHNSTON DAVID BRUCE RANDOLPH ; REINHOLD DONALD FLOYD ; JOBSON RONALD BRADFORD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_FI67389BB3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>fin</language><creationdate>1984</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>STEROIDS</topic><toplevel>online_resources</toplevel><creatorcontrib>RASMUSSON GARY HENRY</creatorcontrib><creatorcontrib>UTNE TORLEIF</creatorcontrib><creatorcontrib>JOHNSTON DAVID BRUCE RANDOLPH</creatorcontrib><creatorcontrib>REINHOLD DONALD FLOYD</creatorcontrib><creatorcontrib>JOBSON RONALD BRADFORD</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>RASMUSSON GARY HENRY</au><au>UTNE TORLEIF</au><au>JOHNSTON DAVID BRUCE RANDOLPH</au><au>REINHOLD DONALD FLOYD</au><au>JOBSON RONALD BRADFORD</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>FRAMSTAELLNING AV SAOSOM 5ALFA-REDUKTAS-INHIBITORER ANVAENDBARA 4-AZA-17-SUBSTITUERAD-5ALFA-ANDROSTAN-3-ONER</title><date>1984-11-30</date><risdate>1984</risdate><abstract>A process for preparing 17 beta -carboxy-4-androsten-3-ones comprising the steps of (1) reacting a 17 beta -(1-ketoethyl)-5-androsten-3-ol, for example, pregnenolene, with pyridine and iodine to form a pyridinium iodide compound; (2) reacting the pyridinium iodide compound with alkali metal methoxide in methanol to form a methyl-5-androsten-3-ol-17 beta carboxylate; (3) oxidizing the product of Step (2) preferably with aluminum isopropoxide to form methyl-4-androsten-3-one-17 beta -carboxylate; and (4) hydrolyzing the product of Step (3) to the corresponding 17 beta -carboxylic acid, salt, or ester. The 17 beta -carboxy-4-androsten-3-ones are useful as intermediates for preparation of N-substituted-17 beta -carbamoylandrost-4-en-3-one and 4-aza-17 beta -substituted-5 alpha -androstan-3-one 5 alpha reductase inhibitors.</abstract><edition>3</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language fin
recordid cdi_epo_espacenet_FI67389BB
source esp@cenet
subjects CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
STEROIDS
title FRAMSTAELLNING AV SAOSOM 5ALFA-REDUKTAS-INHIBITORER ANVAENDBARA 4-AZA-17-SUBSTITUERAD-5ALFA-ANDROSTAN-3-ONER
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T00%3A35%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=RASMUSSON%20GARY%20HENRY&rft.date=1984-11-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EFI67389BB%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true